Does the FDA drop the ball on drug warning labels?
Getty Images
Drug companies write their own drug labels and submit the results of their clinical studies to the FDA. It’s then up to the FDA to review it and ensure that the most critical information makes it on to the drug label. But sometimes facts about side effects and effectiveness are left out and as a result clinicians aren't always getting the prescribing information they need. Is it a result of incomplete or badly organized information submitted by the drug companies or is the FDA's review process to blame?
Also on this episode
Guest:
Dr. Steven Woloshin, associate professor of medicine & of community and family medicine at Dartmouth Medical School; Author of “Lost in Transmission-FDA Drug Information That Never Reaches Clinicians
Comments disabled after 14 days





















